Cetera Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$8.17M Buy
63,633
+32,862
+107% +$3.91M 0.06% 304
2023
Q4
$3.18M Buy
30,771
+11,197
+57% +$1.11M 0.04% 378
2023
Q3
$1.78M Sell
19,574
-4,896
-20% -$431K 0.03% 502
2023
Q2
$1.98M Buy
24,470
+7,962
+48% +$650K 0.03% 466
2023
Q1
$1.31M Buy
16,508
+1,876
+13% +$133K 0.02% 594
2022
Q4
$990K Buy
+14,632
New +$858K 0.02% 678
2016
Q4
Sell
-10,846
Closed -$222K 783
2016
Q3
$222K Sell
10,846
-1,182
-10% -$29.3K 0.02% 640
2016
Q2
$322K Buy
12,028
+1,278
+12% +$35K 0.03% 548
2016
Q1
$289K Buy
10,750
+1,458
+16% +$39.1K 0.02% 535
2015
Q4
$269K Sell
9,292
-1,648
-15% -$45.6K 0.02% 570
2015
Q3
$296K Sell
10,940
-1,976
-15% -$55.9K 0.03% 496
2015
Q2
$353K Sell
12,916
-7,948
-38% -$223K 0.03% 461
2015
Q1
$556K Buy
20,864
+1,388
+7% +$32K 0.05% 362
2014
Q4
$412K Buy
19,476
+4,522
+30% +$101K 0.04% 405
2014
Q3
$357K Buy
+14,954
New +$344K 0.03% 415

Other funds holding NVO